Adler C P, Riede U N, Wurdak W, Zugmaier G
Pathol Res Pract. 1984 Jul;178(6):579-89. doi: 10.1016/S0344-0338(84)80091-6.
In smear preparation of lymph nodes excised from 36 patients with a malignant lymphoma the DNA content was estimated in different tumor cells following Feulgen staining by means of quantitative cytophotometric measurements. The tumors investigated included 11 Hodgkin lymphomas and various types of Non-Hodgkin lymphomas (altogether 25). Whereas the small lymphoid cells found in Hodgkin lymphomas show a diploid DNA content with a wide scattering, in the large mononuclear reticular cells (Hodgkin cells) as well as in Sternberg's giant cells only aneuploid DNA values are seen lying in the hyperdiploid, hypertetraploid and hyperoctoploid regions. DNA stemlines are found in the aneuploid regions, but in some cases they are missing. This indicates that we are dealing with malignant tumor cells. In Non-Hodgkin lymphomas with a low grade of malignancy (centrocytic-centroblastic lymphoma, centrocytic lymphoma, CLL) an aneuploid DNA content is found particularly in the large cells (centroblasts, lymphoblasts) with or without a DNA stemline. These cells must be considered as primary malignant tumor cells. In the immunoblastic lymphoma of high malignancy only aneuploid tumor cells are present showing a particularly intense DNA content in the large immunoblasts, whereas a DNA stemline is usually missing. The range of aneuploid values, the number of polyploid tumor cells and the presence or absence of a DNA stemline are important criterions in determining the degree of malignancy. By means of cytophotometric measurements of the DNA content in the tumor cells of malignant lymphomas it is possible to assertain the degree of malignancy and to establish an objective prognosis.
在对36例恶性淋巴瘤患者切除的淋巴结进行涂片制备时,通过定量细胞光度测量法,在福尔根染色后的不同肿瘤细胞中估计DNA含量。所研究的肿瘤包括11例霍奇金淋巴瘤和各种类型的非霍奇金淋巴瘤(共25例)。霍奇金淋巴瘤中发现的小淋巴细胞显示二倍体DNA含量,分布广泛,而在大单核网状细胞(霍奇金细胞)以及施特恩贝格巨细胞中,仅可见非整倍体DNA值,位于超二倍体、超四倍体和超八倍体区域。在非整倍体区域发现了DNA干系,但在某些情况下缺失。这表明我们处理的是恶性肿瘤细胞。在低恶性度的非霍奇金淋巴瘤(中心细胞-中心母细胞淋巴瘤、中心细胞淋巴瘤、慢性淋巴细胞白血病)中,非整倍体DNA含量尤其在有或无DNA干系的大细胞(中心母细胞、淋巴母细胞)中发现。这些细胞必须被视为原发性恶性肿瘤细胞。在高恶性度的免疫母细胞淋巴瘤中,仅存在非整倍体肿瘤细胞,在大免疫母细胞中显示出特别高的DNA含量,而通常没有DNA干系。非整倍体值的范围、多倍体肿瘤细胞的数量以及DNA干系的存在与否是确定恶性程度的重要标准。通过对恶性淋巴瘤肿瘤细胞中的DNA含量进行细胞光度测量,可以确定恶性程度并建立客观的预后评估。